An OHSU clinical trial suggests older adults with a genetic predisposition to Alzheimer’s disease may benefit from fish oil supplements. The trial, however, didn't demonstrate benefits for people who don't have the APOE4 gene. Lynne Shinto, N.D., says, “Our findings showed that over three years, there was not a statistically significant difference between placebo and the group that took fish oil. I don’t think it would be harmful, but I wouldn’t say you need to take fish oil to prevent dementia.”

An OHSU clinical trial suggests older adults with a genetic predisposition to Alzheimer’s disease may benefit from fish oil supplements. The trial, however, didn't demonstrate benefits for people who don't have the APOE4 gene. Lynne Shinto, N.D., says, “Our findings showed that over three years, there was not a statistically significant difference between placebo and the group that took fish oil. I don’t think it would be harmful, but I wouldn’t say you need to take fish oil to prevent dementia.”

Central Oregon Daily TV highlights the Portland Aerial Tram as an unusual commute for thousands of OHSU employees.

The Lancet Respiratory Medicine reports the FDA has approved the sale of menthol-flavored nicotine vaping products, sparking alarm among pediatricians and public health experts. James Bishara, M.D., says, “As a pediatric cardiologist, I have seen a startling rise in e-cigarette and tobacco product use over the past decade. Failures to restrict the sale of flavored nicotine and tobacco is a lost opportunity to improve the health of the next generation.”

News outlets continue to cover OHSU-led research that reveals a promising approach to developing a universal influenza vaccine, a platform that also could be useful against the next pandemic. Jonah Sacha, M.D., says, “For viruses of pandemic potential, it’s critical to have something like this. We set out to test influenza, but we don’t know what’s going to come next.”

An OHSU clinical trial suggests older adults with a genetic predisposition to Alzheimer’s disease may benefit from fish oil supplements. The trial, however, didn't demonstrate benefits for people who don't have the APOE4 gene. Lynne Shinto, N.D., says, “Our findings showed that over three years, there was not a statistically significant difference between placebo and the group that took fish oil. I don’t think it would be harmful, but I wouldn’t say you need to take fish oil to prevent dementia.”

An OHSU clinical trial suggests older adults with a genetic predisposition to Alzheimer’s disease may benefit from fish oil supplements. The trial, however, didn't demonstrate benefits for people who don't have the APOE4 gene. Lynne Shinto, N.D., says, “Our findings showed that over three years, there was not a statistically significant difference between placebo and the group that took fish oil. I don’t think it would be harmful, but I wouldn’t say you need to take fish oil to prevent dementia.”

David Lieberman, M.D., weighs in on a new FDA-approved blood-based screening test for colorectal cancer. He says the blood-based test is “better than no screening,” but cautions that it is “inferior to other screening tests and should not replace one of the established screening tests.”

A financial earnings press release from ORYZON mentions that OHSU has opened an investigator-initiated study to evaluate the combination of iadademstat with venetoclax and azacitidine in patients with acute myeloid leukemia (AML).

Article focuses on OHSU-led research that reveals a promising approach to developing a universal influenza vaccine, a platform that also could be useful against the next pandemic. Jonah Sacha, M.D., says, “For viruses of pandemic potential, it’s critical to have something like this. We set out to test influenza, but we don’t know what’s going to come next.”